Navigation Links
Brazilian, Russian, Indian and Chinese Urological Device Markets Set to Reach a Value of More Than $1.4 Billion by 2022
Date:11/19/2013

TORONTO, Nov. 19, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Brazilian, Russian, Indian and Chinese (BRIC) markets for urological devices will expand strongly through 2022 as a result of rapid economic growth coupled with increased government investment in healthcare.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO)

Within the urological device market, urinary incontinence devices generate the bulk of revenues. The market for these devices will grow at an average annual rate of about eight percent through 2022. Among urinary incontinence (UI) devices, urinary catheters will account for more than half of revenues. While intermittent catheters are widely available in the US and Europe, BRIC countries most often use Foley catheters, because of their lower cost. Intermittent catheters were not even available in India in 2013.

International competitors have shown strong interest in these potentially lucrative markets. However, UI devices, particularly urinary catheters, are fairly simple to develop and many domestic competitors also offer these products, resulting in highly fragmented markets with strong price competition. For example, the Brazilian Foley catheter market only contained domestic competitors in 2013. In India, one particularly successful local competitor is Romsons, which held approximately one-quarter of the urinary incontinence device market share in 2013.

"Despite these challenges, more multinational competitors are anticipated to enter the BRIC urological device markets through 2022 as these markets continue to grow," said MRG Analyst Jennifer Smith. "So far, however, these companies have had the most success in mo
'/>"/>

SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Brazilian, Russian, Indian and Chinese Markets For Electrophysiology Mapping and Ablation Devices Will See Rapid Growth Through 2022
2. Brazilian, Indian and Chinese Orthopedic Markets to See Strong Growth Through 2017
3. Indiana Biosciences Research Institute Hits $50 Million Start-Up Funding Goal
4. 1,200th Worldwide Implant of the SynCardia Total Artificial Heart Occurs in Indiana
5. Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
6. Lilly Statement on Indiana Biosciences Research Institute
7. Contract Manufacturer RMI hosts Central Indiana Jobs Roundtable with U.S. Senator Joe Donnelly
8. CHPA Statement on Statewide Indiana Consumer Poll
9. 50 Indian Companies to Collectively Invest $500 Million in US Market
10. The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market
11. Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)...  An International Trade Commission (ITC) ruling issued Friday ... device, Taiwanese device manufacturer APEX continues to infringe ResMed ... ) is the innovation leader and pioneer in designing ... "Our research and development teams are ... of comfort, performance and efficacy," said David Pendarvis ...
(Date:7/21/2014)... Apex Medical Corporation (Apex, TWSE: 4106), a leading player ... announces that the United States International Trade Commission (USITC) ... newly designed XT series continuous positive airway pressure (CPAP) ... the patent claims asserted by ResMed, one of Apex,s ... an upgraded iCH water tank to the market in ...
(Date:7/18/2014)... 2014 Hanger, Inc. (NYSE: HGR ) ... operations for the quarter ended June 30, 2014, on Tuesday, ... to discuss these results is scheduled to begin at 9:00 ... participate should call 1-877-662-6095. A replay will be available until ... ID # 44683027. About Hanger, Inc. – Built ...
Breaking Medicine Technology:ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents 2Apex Medical's Respiratory Therapy Product Receives Affirmation from USITC 2
... an international generic pharmaceuticals company, today announced that ... Food & Drug Administration to market Zolpidem Tartrate ... the product has commenced.   Actavis ... Extended-Release Tablets 6.25 mg strength in October 2010 with ...
... 6, 2011 Pharmacyclics, Inc. (Nasdaq: PCYC ... the Phase IB/II study of the Btk inhibitor, PCI-32765, ... (CLL/SLL) at the 2011 American Society of Clinical Oncology ... development program update for the Btk Inhibitor, PCI-32765.  The ...
Cached Medicine Technology:Actavis Receives FDA Approval of Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV in the U.S. 2Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 2Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 3Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 4Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 5Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 6Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 7Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 8Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765 9
(Date:7/21/2014)... July 21, 2014 What do romance, ... have in common? You can find them all in ... novel's main character, Miranda, lives on Martha’s Vineyard with ... a wealthy New Yorker, and becomes entangled in a ... Heart challenges readers to think about what choices they ...
(Date:7/21/2014)... (Philadelphia, PA) Patients who have a clot ... be treated with traditional blood-thinning medication or undergo ... comfortable that there is no difference in death ... more bleeding risks with the catheter procedure, according ... Medicine researchers. The study involved a review of ...
(Date:7/21/2014)... (PRWEB) July 21, 2014 Executives ... agency specializing in private healthcare practices, will participate ... (IACA). They will be showcasing their state-of-the-art capabilities ... medical practices all over the United States as ... efforts continues to increase. Advice Media’s presence at ...
(Date:7/21/2014)... MONDAY, July 21, 2014 (HealthDay News) -- The "viral ... avoiding detection and elimination, is established much earlier than ... poses new obstacles for those working to eradicate the ... Military HIV Research Program. They said the presence of ... finding a cure for a subtype of HIV, known ...
(Date:7/21/2014)... Public Affairs Research has released the results of a ... means to be a quality health care provider in ... Wood Johnson Foundation, sheds new light on how American ... doctors, as well as the information they use and ... new and actionable data during a crucial period of ...
Breaking Medicine News(10 mins):Health News:Thea Marsh Releases Debut Novel that Celebrates and Reaches out to Women Everywhere 2Health News:Temple study compares deep vein thrombosis therapies 2Health News:Temple study compares deep vein thrombosis therapies 3Health News:Temple study compares deep vein thrombosis therapies 4Health News:Advice Media to Attend the International Association of Comprehensive Aesthetics Conference (IACA) Targeting the Dental Profession 2Health News:Animal Experiments Shed Light on HIV's Ability to Hide 2Health News:National survey from AP-NORC examines perceptions of health care provider quality 2
... Central government and striking medicos to end the agitation ... Castes// in educational institutes failed to reach any conclusion ... decision to implement the 27% reservation for OBCs in ... that they would plan to make their agitation 'more ...
... to a study it was found that a number ... measures, like a daily dose of aspirin, colon cancer ... young women, immunizing adults against the flu and pneumonia ... longer and healthier lives. The study’s results were published ...
... Ranbaxy Laboratories Limited today entered into an in-licensing agreement ... (NDDS) analgesic // , Tramadol in the Indian market ... the wholly-owned subsidiary of the French drug major for ... ,The product will be supplied from Ethypharm's manufacturing ...
... Laboratories Limited today said the World Health Organistion has ... products in its pre-qualification list. // ,The ... 200mg capsules, Stavudine 30mg capsules, Stavudine 40mg capsules, the ... significant development. We strongly feel that Generic ARVs are ...
... aroused as fear about childhood obesity grows and thus ... ... child-sized machines, during the past two years. ... Shokk and Zig Zag was building new facilities and installing machines for their little customers. ,According to ...
... Cabinet today cleared the business model for the state-of-the-art Institute ... the capital. // ,The model approved by the ... would enable the institute to be self-sufficient in nine years' ... the finances for procuring medical equipment would be borne by ...
Cached Medicine News:Health News:Disappointed Students Plan To Intensify Agitation Nationwide 2
Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
Medicine Products: